Abrysvo had previously been approved for adults 60-years and older.
Mike Hollan
Advertisement
Mike Hollan is an assistant managing editor for Pharmaceutical Executive and Medical Device and Technology and can be reached at mhollan@mjhlifesciences.com.
Articles by Mike Hollan
The current phase of the campaign is focused on family conversations during holiday gatherings.
The meeting is set to focus on advancing smoking cessation.
The gallery will be presented at the HLTH 2024 conference.
The guidelines, titled BRIDGE, are set to be released in 2025.
People suffering from the condition reportedly struggle to find public restrooms in emergencies.
The study, released by Otsuka, reveals that caregivers perform the work of highly paid professionals.
The company includes the technology in drug development, improving efficiency, and other areas.
Sun Life U.S. teamed up with several other Florida-based companies to provide needed assistance in areas impacted by the recent storms.
The organization hopes to collect data to provide better education around Thrombosis.
Slope’s CEO and co-founder discusses technological advances that are solving problems with data collection and sorting from clinical trials.
Dr. Sandra Lee is joining the educational program, which originally launched last year.
Industry leaders gather to discuss different ways life sciences organizations can champion their environmentally-conscious younger employees while combatting still-entrenched public mistrust.
S-HiCon can reportedly achieve stable liquid formulation for over 200 mg/mL subcutaneous administration.
MedHub has been expanded to work with a wider variety of insurance plans.
Rafaat Rahmani, president and founder of Lifescience Dynamics, grew up in abject poverty, but such hardships—and a later violent brush with racism—would ultimately end up fueling a determined and entrepreneurial path in the life sciences.
Roaldi previously served as chief growth officer for UnitedHealthcare Community & State.
Respondents showed concern for cost increases and changes to benefits.
The campaign comes during a time when the nation is facing a blood shortage.
Announcements such as Apple’s come with pros and cons for industry.
The two companies will continue to collaborate on weight loss medications.
The program will now cover 15 gene and cell therapies.
Sustainable diet habits include behaviors like sticking to a diet plan and avoiding alcohol.
The partnership will provide plan members with access to digital services aimed at older patients.
Pending regulatory approval, the two companies will form a new company named NewCo.
The locations were spread across 37 different states.
The event, part of the #CheckYourFoodTube campaign, was held in Cincinnati, Ohio.
The stop loss is designed to protect against potentially massive costs related to gene therapy treatments.
Dr. Wagner discusses her work with the Bill and Melinda Gates Medical Research Institute.
The campaign is called #BustTheMyth and is aimed at patient education.
Advertisement